DCF — ANAHEIM GLOBAL MEDICAL CENTER
Enterprise Value: $22.4M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$22.4M
Enterprise Value
$5.8M
PV of Cash Flows
$16.6M
PV of Terminal Value
$26.8M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $31.4M | $3.0M | 9.0% | $1.1M | $1.0M |
| Year 2 | $32.4M | $3.4M | 10.0% | $1.4M | $1.1M |
| Year 3 | $33.4M | $3.8M | 11.0% | $1.7M | $1.2M |
| Year 4 | $34.4M | $4.1M | 12.0% | $1.8M | $1.3M |
| Year 5 | $35.4M | $4.3M | 12.0% | $2.0M | $1.2M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $22.4M. Terminal value accounts for 74% of total EV — typical range (60-80%).
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$30.5M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base0.08935229856483401
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5